Aarkstore.com || Vancomycin-Resistant Enterococcus Faecium Infections || Market Research

1. Aarkstore.com announces, The Latest market research report is available in
its vast collection:
Vancomycin-Resistant Enterococcus Faecium Infections –
Pipeline Review, H2 2012
You can also request for sample page of above mention reports on
sample@aarkstore.com
Summary
Global Markets Direct’s, Vancomycin-Resistant Enterococcus Faecium Infections -
Pipeline Review, H2 2012, provides an overview of the Vancomycin-Resistant
Enterococcus Faecium Infections therapeutic pipeline. This report provides
information on the therapeutic development for Vancomycin-Resistant
Enterococcus Faecium Infections, complete with latest updates, and special features
on late-stage and discontinued projects. It also reviews key players involved in the
therapeutic development for Vancomycin-Resistant Enterococcus Faecium
Infections. Vancomycin-Resistant Enterococcus Faecium Infections - Pipeline
Review, H2 2012 is built using data and information sourced from Global Markets
Direct’s proprietary databases, Company/University websites, SEC filings, investor
presentations and featured press releases from company/university sites and
industry-specific third party sources, put together by Global Markets Direct’s team.
Note*: Certain sections in the report may be removed or altered based on the
availability and relevance of data for the indicated disease.
Scope
- A snapshot of the global therapeutic scenario for Vancomycin-Resistant
Enterococcus Faecium Infections.
- A review of the Vancomycin-Resistant Enterococcus Faecium Infections products
under development by companies and universities/research institutes based on
information derived from company and industry-specific sources.

2. - Coverage of products based on various stages of development ranging from
discovery till registration stages.
- A feature on pipeline projects on the basis of monotherapy and combined
therapeutics.
Table of contents:
List of Tables 4
List of Figures 5
Introduction 6
Global Markets Direct Report Coverage 6
Vancomycin-Resistant Enterococcus Faecium Infections Overview 7
Therapeutics Development 8
An Overview of Pipeline Products for Vancomycin-Resistant Enterococcus Faecium
Infections 8
Vancomycin-Resistant Enterococcus Faecium Infections Therapeutics under
Development by Companies 10
Late Stage Products 12
Comparative Analysis 12
Mid Clinical Stage Products 13
Comparative Analysis 13
Early Clinical Stage Products 14
Comparative Analysis 14
Discovery and Pre-Clinical Stage Products 15
Comparative Analysis 15
Vancomycin-Resistant Enterococcus Faecium Infections Therapeutics – Products
under Development by Companies 16
Companies Involved in Vancomycin-Resistant Enterococcus Faecium Infections
Therapeutics Development 17
Ceragenix Pharmaceuticals, Inc. 17
Piramal Healthcare Limited 18
Wockhardt Limited 19
Paratek Pharmaceuticals, Inc. 20
Immtech Pharmaceuticals, Inc. 21
Lorus Therapeutics Inc 22
Oragenics, Inc. 23

3. MerLion Pharmaceuticals Pte Ltd 24
MicuRx Pharmaceuticals, Inc. 25
Trius Therapeutics, Inc. 26
Vancomycin-Resistant Enterococcus Faecium Infections – Therapeutics Assessment
27
Assessment by Monotherapy Products 27
Assessment by Route of Administration 28
Assessment by Molecule Type 30
Drug Profiles 32
LOR-220 - Drug Profile 32
Product Description 32
Mechanism of Action 32
R&D Progress 32
List of Figures
List of Tables are also include.
For more related Reports Plz follow The link:
Pipeline Review, H2 2012
http://www.aarkstore.com/search/viewresults.asp?search=Pipeline Review, H2
2012&PubId=&pagenum=1
Myocardial Ischemia – Pipeline Review, H2 2012
Primary Immune Deficiency (PID) – Pipeline Review, H2 2012
Vancomycin-Resistant Enterococcus Faecium Infections – Pipeline Review, H2 2012

4. Intra Dialytic Hypotension – Pipeline Review, H2 2012
Poisoning – Pipeline Review, H2 2012
Edema – Pipeline Review, H2 2012
Coronary Stenosis – Pipeline Review, H2 2012
Hypoglycemia – Pipeline Review, H2 2012
Nasopharyngitis (Common Cold) – Pipeline Review, H2 2012
AIDS Associated Dementia – Pipeline Review, H2 2012
Open-Angle Glaucoma – Pipeline Review, H2 2012
Search More Reports Related to This Category :
Pharmaceuticals and Healthcare
http://www.aarkstore.com/search/viewresults.asp?search=Pharmaceuticals and
Healthcare&PubId=&pagenum=1
For More details Plz do contact :
Aarkstore Enterprise
Lavanya
Phone:08149852585
Email: enquiry@aarkstore.com